Madison Vaccines
VerifiedMadison Vaccines Incorporated develops vaccines for patients with prostate cancer and a test to identify such patients.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$13—20m (Dealroom.co estimates Jan 2017.)
Menomonie Wisconsin (HQ)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor investor investor | $0.0 | round | |
investor investor investor investor | $0.0 | round | |
investor | $0.0 | round | |
$3.3m | Early VC | ||
Total Funding | 000k |
Related Content
Recent News about Madison Vaccines
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.